A Phase IV Open-Label Pharmacokinetic Study of Minocycline for Injection Following a Single Infusion in Critically-Ill Adults (ACUMIN)
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Minocycline (Primary)
- Indications Gram-negative infections
- Focus Pharmacokinetics
- Acronyms ACUMIN
- 15 Aug 2019 Status changed from recruiting to completed.
- 09 May 2019 Planned End Date changed from 31 Jan 2019 to 1 Aug 2019.
- 09 May 2019 Planned primary completion date changed from 31 Jan 2019 to 1 Aug 2019.